Posted On: 05/30/2013 3:32:15 PM
Post# of 72433
![Avatar](https://investorshangout.com/images/ProfileImages/1087402152_3060_1351737293781_funny-pictures.jpg)
I actually think this is a big event but not for share price. We have oncologists and researchers from all over the world attending ASCO. As the trial progresses past phase 1 and enters combined drug and possibly a stand alone trial. We will need patients for these trials to progress quicker especially for more rare diagnosis such as retinoblastoma.
An oncologist six months from now could get a patient that meets the criteria for a trial and remember they saw a trial at ASCO and send over a referral.
And of course these researchers and oncologists could be investors also.
An oncologist six months from now could get a patient that meets the criteria for a trial and remember they saw a trial at ASCO and send over a referral.
And of course these researchers and oncologists could be investors also.
![](/m/images/icons/icon_smile.gif)
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)